Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | MGAM | O43451 | 1/20 | 0.50 |
| ▸ | SI | P14410 | 1/20 | 0.50 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | CAD | P27708 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL796619 | 0.86 | GAA (0.48) | GAAMGAMSIMGAM2L3MBTL1 | |
| SCHEMBL22111168 | 0.86 | GAA (0.48) | GAAMGAMSIMGAM2L3MBTL1 | |
| SCHEMBL14951131 | 0.83 | CAD (0.41) | GAAMGAMSIMGAM2L3MBTL1 | |
| SCHEMBL8583393 | 0.83 | GAA (0.50) | GAAMGAMSIMGAM2L3MBTL1 | |
| SCHEMBL22111291 | 0.83 | CAD (0.41) | GAAMGAMSIMGAM2L3MBTL1 | |
| SCHEMBL8583399 | 0.83 | GAA (0.50) | GAAMGAMSIMGAM2L3MBTL1 | |
| SCHEMBL17586072 | 0.83 | NAAA (0.51) | L3MBTL1KMT2ATSHR | |
| SCHEMBL10612838 | 0.82 | GAA (0.48) | GAAMGAMSIMGAM2L3MBTL1 | |
| SCHEMBL9729395 | 0.82 | GAA (0.48) | GAAMGAMSIMGAM2L3MBTL1 | |
| SCHEMBL2734760 | 0.80 | CAD (0.44) | GAAMGAMSIMGAM2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3990553-B1 | USE OF COATING COMPOSITIONS FOR WIND TURBINE BLADES | HEMPEL AS (DK) | 2023-06-07 | — | — | EP | disclosed |
| EP-2861684-B1 | CURABLE POLYUREA FORMING COMPOSITION, METHOD OF MAKING, AND COMPOSITE ARTICLE | 3M INNOVATIVE PROPERTIES CO (US) | 2016-03-30 | — | — | EP | disclosed |
| US-9238617-B2 | Polyureas made from aminocrotonates | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2016-01-19 | — | — | US | disclosed |
| US-9198971-B2 | Injectable solution at pH 7 comprising at least one basal insulin the pI of which is between 5.8 and 8.5 and a substituted co-polyamino acid | ADOCIA (FR) | 2015-12-01 | — | — | US | disclosed |
| US-20150232416-A1 | POLYUREAS MADE FROM AMINOCROTONATES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2015-08-20 | — | — | US | disclosed |
| US-9051489-B2 | Polyureas made from aminocrotonates | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2015-06-09 | — | — | US | disclosed |
| US-20150104652-A1 | CURABLE POLYUREA FORMING COMPOSITION, METHOD OF MAKING, AND COMPOSITE ARTICLE | 3M INNOVATIVE PROPERTIES COMPANY | 2015-04-16 | — | — | US | disclosed |
| US-20140234546-A1 | POLYUREAS MADE FROM AMINOCROTONATES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2014-08-21 | — | — | US | disclosed |
| US-8710170-B2 | Polyureas made from aminocrotonates and enaminones | The United States of Americas, as represented by the Secretary of the Navy (US) | 2014-04-29 | — | — | US | disclosed |
| US-20130178415-A1 | Injectable solution at pH 7 comprising at least one basal insulin the PI of which is between 5.8 and 8.5 and a substituted co-polyamino acid | ADOCIA (FR) | 2013-07-11 | — | — | US | disclosed |
| US-20090285994-A1 | POLYUREAS MADE FROM AMINOCROTONATES AND ENAMINONES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090285994-A1 | POLYUREAS MADE FROM AMINOCROTONATES AND ENAMINONES | ODC1, ALKBH1, ALKBH3 | GAA 1793/4885MGAM 1362/4885SI 967/4885 |
| US-20150232416-A1 | POLYUREAS MADE FROM AMINOCROTONATES | SIGMAR1, NPY1R, OGFR | GAA 1914/4885MGAM 1685/4885SI 1261/4885 |
| US-20130178415-A1 | Injectable solution at pH 7 comprising at least one basal insulin the PI of which is between 5.8 and 8.5 and a substituted co-polyamino acid | IAPP, VIP, IGFBP1 | GAA 1168/4885MGAM 1587/4885SI 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.